ADA 2025
20 - 23 June 2025
Oral Semaglutide and Cardiovascular Outcomes by Baseline A1c and BMI in People with Type 2 Diabetes in the SOUL Trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.